RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genor Biopharma Holdings Stock

Genor Biopharma Holdings Equity 2024

Genor Biopharma Holdings Equity

1.19 B CNY

Ticker

6998.HK

ISIN

KYG3871A1004

WKN

A3C3E0

In 2024, Genor Biopharma Holdings's equity was 1.19 B CNY, a -34.05% increase from the 1.8 B CNY equity in the previous year.

Genor Biopharma Holdings Aktienanalyse

What does Genor Biopharma Holdings do?

Genor Biopharma Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Genor Biopharma Holdings's Equity

Genor Biopharma Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genor Biopharma Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Genor Biopharma Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Genor Biopharma Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Genor Biopharma Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Genor Biopharma Holdings stock

What is the equity of Genor Biopharma Holdings this year?

Genor Biopharma Holdings has equity of 1.19 B CNY this year.

What was the equity of Genor Biopharma Holdings compared to the previous year?

The equity of Genor Biopharma Holdings has increased/decreased by -34.05% decreased compared to the previous year.

What impact does a high equity have on investors of Genor Biopharma Holdings?

A high equity is advantageous for investors of Genor Biopharma Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Genor Biopharma Holdings?

A low equity can be a risk for investors of Genor Biopharma Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Genor Biopharma Holdings affect the company?

An increase in equity of Genor Biopharma Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Genor Biopharma Holdings affect the company?

A reduction in equity of Genor Biopharma Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Genor Biopharma Holdings?

Some factors that can affect the equity of Genor Biopharma Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Genor Biopharma Holdings so important for investors?

The equity of Genor Biopharma Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Genor Biopharma Holdings take to change the equity?

To change equity, Genor Biopharma Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Genor Biopharma Holdings pay?

Over the past 12 months, Genor Biopharma Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genor Biopharma Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genor Biopharma Holdings?

The current dividend yield of Genor Biopharma Holdings is .

When does Genor Biopharma Holdings pay dividends?

Genor Biopharma Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genor Biopharma Holdings?

Genor Biopharma Holdings paid dividends every year for the past 0 years.

What is the dividend of Genor Biopharma Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genor Biopharma Holdings located?

Genor Biopharma Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genor Biopharma Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genor Biopharma Holdings from 12/18/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Genor Biopharma Holdings pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Genor Biopharma Holdings in the year 2023?

In the year 2023, Genor Biopharma Holdings distributed 0 CNY as dividends.

In which currency does Genor Biopharma Holdings pay out the dividend?

The dividends of Genor Biopharma Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genor Biopharma Holdings

Our stock analysis for Genor Biopharma Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genor Biopharma Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.